Reversible pegylated drugs

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7585837
SERIAL NO

11244402

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Reversible pegylated drugs are provided by derivatization of free functional groups of the drug selected from amino, hydroxyl, mercapto, phosphate and/or carboxyl with groups sensitive to mild basic conditions such as 9-fluorenylmethoxycarbonyl (Fmoc) or 2-sulfo-9-fluorenylmethoxycarbonyl (FMS), to which group a PEG moiety is attached. In these pegylated drugs, the PEG moiety and the drug residue are not linked directly to each other, but rather both residues are linked to different positions of the scaffold Fmoc or FMS structure that is highly sensitive to bases and is removable under physiological conditions. The drugs are preferably drugs containing an amino group, most preferably peptides and proteins of low or medium molecular weight. Similar molecules are provided wherein a protein carrier or another polymer carrier replaces the PEG moiety.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
YEDA RESEARCH AND DEVELOPMENT CO LTDREHOVOT REHOVOT CENTRAL DISTRICT

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fridkin, Matityahu Rehovot , IL 45 752
Shechter, Yoram Rehovot , IL 19 474
Tsubery, Haim Elad , IL 11 364

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation